Home

Alkem Laboratories Ltd EPS

Image

Alkem Laboratories Ltd

NSE: ALKEM

EPS

₹ 190.19

Last updated on: Oct 09, 2025

Key Highlights

  • The Earning per Share of Alkem Laboratories Ltd is ₹ 190.19 as of 09 Oct 25 .
  • The earning per share of Alkem Laboratories Ltd changed from ₹ 23.98 to ₹ 55.56 over 9 quarters. This represents a CAGR of 45.27% .

Historical Earning per Share of Alkem Laboratories Ltd

No data available

* All values are in

Company Fundamentals for Alkem Laboratories Ltd

Market Cap

65,195 Cr

EPS

190.2

P/E Ratio (TTM)

28.8

P/B Ratio (TTM)

5.5

Day’s High

5494.45

Day’s Low

5415.0

DTE

0.1

ROE

18.1

52 Week High

6369.0

52 Week Low

4498.9

ROCE

19.3

Market Price of Alkem Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Alkem Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
10 Oct 20255452.7
09 Oct 20255476.1
08 Oct 20255492.2
07 Oct 20255488.7
06 Oct 20255489.4
03 Oct 20255434.2
01 Oct 20255460.15
30 Sep 20255422.2
29 Sep 20255407.2
26 Sep 20255425.95

SWOT Analysis Of Alkem Laboratories Ltd

Strength

3

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Alkem Laboratories Ltd

Asset Value vs Market Value of Alkem Laboratories Ltd

Market Value

65,475

Asset Value

Value addition

4.5 X

11,880

* All values are in ₹ crores

Competitive Comparison of EPS

Company
leftMarket Capright
Alkem Laboratories Ltd65474
Sun Pharmaceutical Industries Ltd400893
Divis Laboratories Ltd171976
Cipla Ltd126137
Torrent Pharmaceuticals Ltd119706
Dr Reddys Laboratories Ltd105562

Historical Market Cap of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Revenue of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical EBITDA of Alkem Laboratories Ltd

No data available

* All values are in crore

Historical Net Profit of Alkem Laboratories Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Alkem Laboratories Ltd News Hub

Alkem Labs PAT soars 90% YoY to Rs 545 crore in Q1

Revenue from operations stood at Rs 3,031.82 crore in June 2024 quarter, registering a growth of 2.1

Read more

09 Aug 24

Alkem Laboratories consolidated net profit rises 90.13% in the June 2024 quarter

Net profit of Alkem Laboratories rose 90.13% to Rs 545.16 crore in the quarter ended June 2024 as ag

Read more

09 Aug 24

Alkem Laboratories Ltd soars 3.33%, rises for fifth straight session

Alkem Laboratories Ltd rose for a fifth straight session today. The stock is quoting at Rs 5695.7, u

Read more

08 Aug 24

Alkem Laboratories Ltd rises for third consecutive session

Alkem Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 5407.35

Read more

06 Aug 24

Document

Annual Reports

Annual Report 2022

dropdown
download

Credit Ratings

Credit Report 2022

dropdown
download

FAQs for EPS of Alkem Laboratories Ltd

What is the EPS of Alkem Laboratories Ltd stock?

The Earnings Per Share (EPS) of Alkem Laboratories Ltd is 190.19. An EPS is the amount of net income attributed to each share of a common stock.

How is Alkem Laboratories Ltd EPS calculated?

The EPS of Alkem Laboratories Ltd is calculated by dividing the net income by the number of outstanding shares. The formula is EPS = (Net Income - Dividends on Preferred Stock) / Average Outstanding Shares.

How often does Alkem Laboratories Ltd report its EPS?

Alkem Laboratories Ltd typically reports its EPS quarterly and annually, in conjunction with its financial statements and earnings reports.

What factors can influence Alkem Laboratories Ltd EPS?

Factors that influence the EPS of Alkem Laboratories Ltd include revenue changes, cost fluctuations, operational efficiency, tax rates, and one-time gains or losses.

Can Alkem Laboratories Ltd EPS growth indicate future performance?

Yes, consistent growth in Alkem Laboratories Ltd EPS can suggest strong financial health and effective management, potentially indicating positive future performance.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions